Mode
Text Size
Log in / Sign up
Phase 2 N=24 Randomized Triple-blind Treatment

Efficacy of Steroid Supplementation After TMJ Rinsing for Pain Management

Pain

Enrolled (actual)
24
Serious AEs
0.0%
Results posted
Oct 2020
Primary outcome: Primary: Change From Pre-Treatment in TMJ Loading Pain Rating at 12 Weeks — -1; -2 units on a scale

Study Design & Population

Study type
Interventional
Phase
Phase 2
Interventions
Lactated Ringers (Drug); Triamcinolone hexacetonide (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
Female
Sponsor
University of Florida
Primary completion
Jan 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Change From Pre-Treatment in TMJ Loading Pain Rating at 12 Weeks
-1; -2
SECONDARY
Change From Pre-Treatment in TMJ Loading Pain Rating at 2 Weeks
-1; -2
SECONDARY
Change From Pre-Treatment in TMJ Loading Pain Rating at 6 Weeks
-1; -2
SECONDARY
Change From Pre-Treatment in Mandibular Range of Motion Without Pain at 2 Weeks
3.9; 9.7
SECONDARY
Change From Pre-Treatment in Mandibular Range of Motion at 6 Weeks
6.9; 7.4
SECONDARY
Change From Pre-Treatment in Mandibular Range of Pain-Free Motion at 12 Weeks
5.3; 10.0
SECONDARY
Change From Pre-Treatment Palpable Muscle Tenderness at 2 Weeks
-2; -1
SECONDARY
Change From Pre-Treatment Palpable Muscle Tenderness at 6 Weeks
-1; -1
SECONDARY
Change From Pre-Treatment Palpable Muscle Tenderness at 12 Weeks
0; -2
SECONDARY
Number of Participants With Change From Pre-Treatment Joint Sounds in 2 Weeks
1; 5
SECONDARY
Number of Participants With Change From Pre-Treatment Joint Sounds in 6 Weeks
3; 6
SECONDARY
Number of Participants With Change From Pre-Treatment Joint Sounds in 12 Weeks
4; 5
SECONDARY
Change From Pre-Treatment Functional Pain (Chewing) at 2 Weeks
-30; -37
SECONDARY
Change From Pre-Treatment Functional Pain (Chewing) at 6 Weeks
-33; -47
SECONDARY
Change From Pre-Treatment Functional Pain (Chewing) at 12 Weeks
-26; -43

Summary

The hypothesis to be tested is temporomandibular joint (TMJ) rinsing followed by steroid injection is more efficacious than a placebo injection based on standard pain and physical measures that are recorded before and after treatment. All procedures will be the same as if following normal TMJ arthrocentesis (rinsing) clinical care except that the patient will be randomly assigned to one of two groups: (1) TMJ rinsing followed by the injection of 1 cc (about ¼ of a teaspoon) of the same rinsing solution (this is the placebo) into the jaw joint; or (2) TMJ rinsing followed by the injection of 1 cc (about ¼ teaspoon) of a steroid (5 mg of triamcinolone hexacetonide) into the jaw joint. A pregnancy test (urine test) will be conducted on all women of child-bearing age to verify that the patient is not pregnant before the rinsing procedure. The patient will fill out a short questionnaire and have a short exam of the TMJ and jaw muscles at each appointment.

Eligibility Criteria

Inclusion Criteria

  • Female
  • 18-80 years of age
  • TMJ arthralgia
  • Masticatory myalgia
  • TMJ sounds
  • History of at least 6 weeks use of occlusal appliance therapy

Exclusion Criteria

  • Contraindication to sedation including pregnancy or medical history
  • History of previous TMJ procedure including arthrocentesis, arthroscopy or arthrotomy
  • History of steroidal injection into TMJ
  • History of trauma to TMJ
  • TMJ pain longer than 3 years
  • History of narcotic drug use on a scheduled basis
  • Current active infection
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01770912). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search